# A Randomized Acceptability and Safety Study of the Transfer From Subutex to Suboxone in Opioid- Dependent Subjects (Study P04843)(COMPLETED)

> **NCT00605033** · PHASE4 · COMPLETED · sponsor: **Indivior Inc.** · enrollment: 241 (actual)

## Conditions studied

- Opiate Dependence
- Drug Dependence

## Interventions

- **DRUG:** Suboxone, Buprenorphine Hydrochloride + Naloxone, SCH 484
- **DRUG:** Subutex, Buprenorphine Hydrochloride, SCH 28444

## Key facts

- **NCT ID:** NCT00605033
- **Lead sponsor:** Indivior Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2009-04
- **Final completion:** 2009-05
- **Target enrollment:** 241 (ACTUAL)
- **Last updated:** 2016-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00605033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00605033, "A Randomized Acceptability and Safety Study of the Transfer From Subutex to Suboxone in Opioid- Dependent Subjects (Study P04843)(COMPLETED)". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00605033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*